ACAD を保有するビリオネア

ビリオネア ポートフォリオ内保有比率 保有株数(百万株) % 平均取得コスト 平均取得コスト リターン

ファンダメンタルズ

  • N/A
    株価収益率(PER)

  • 0.0
    利回り(%)

  • 100百万ドル
    発行済み株式数

  • 2988B
    時価総額

News & Insights

ABOUT

ACAD

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by Pimavanserin th...

Three Main Takeaways From Soros’ Open-Ed On The Brexit

NEWS

Soros, Druckenmiller among hedgies profiting in market plunge

READ MORE